Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1993-05-20
1995-07-04
Warden, Jill
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 11, A61K 3700, A61K 3174, A61K 3800
Patent
active
054300177
ABSTRACT:
The invention relates to a pharmaceutical composition for oral administration containing cyclosporin A and/or cyclosporin G as active ingredient, which possess advantageous absorption characteristics, and to a process for preparing this composition. The composition according to the invention comprises 1 part by mass of one or more cyclosporin(s) dissolved in 4 to 50 parts by volume of propylene glycol, 0 to 25 parts by volume of ethanol and 0.0 to 5 parts by mass of a polyoxyethylene/polyoxypropylene block polymer in homogenized state. Based on examinations carried out at 100.degree. C., the stability of solutions prepared according to the invention does not differ from that of the commercially available Sandimmun oral solution.
REFERENCES:
patent: 4649047 (1987-03-01), Kagwari
patent: 4996193 (1991-02-01), Hewitt et al.
patent: 5051402 (1991-09-01), Kurihara et al.
Antalne Kovacs
Erno Orban
Erzsebet Takacs
Imre Moravcsik
Istvan Kovacs
Biogal Gyogyszergvar RT
Touzeau Lynn
Warden Jill
LandOfFree
Oral pharmaceutical composition containing cyclosporin and proce does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oral pharmaceutical composition containing cyclosporin and proce, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oral pharmaceutical composition containing cyclosporin and proce will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-760090